Details for Patent: 11,207,280

Which drugs does patent 11,207,280 protect, and when does it expire?

Patent 11,207,280 protects ADRENALIN and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 11,207,280

Title:	Epinephrine compositions and containers
Abstract:	The inventive subject matter provides ready-to-administer, preferably anti-oxidant free, epinephrine compositions with improved stability, and methods for preparing the same. Contemplated compositions can be packaged using blow-fill-seal technology or packaged into flexible IV bags and maintain degradation of the epinephrine at a level of less than 5 wt % when stored over at least one months at between 2-40° C.
Inventor(s):	Prem Sagar Akasapu, Kumaresh Soppimath, Reema Ajitkumar Puri, Iouri V. Ilitchev, Milan Patel, Pooja H. Tendulkar
Assignee:	Nevakar Injectables Inc
Application Number:	US16/821,785
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,207,280
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 11,207,280

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAVENOUS	215875-001	Apr 21, 2023		RX	Yes	Yes	11,207,280		Y
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAVENOUS	215875-002	Apr 21, 2023		RX	Yes	Yes	11,207,280		Y
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAVENOUS	215875-003	Apr 21, 2023		RX	Yes	Yes	11,207,280		Y
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAVENOUS	215875-004	Apr 21, 2023		RX	Yes	Yes	11,207,280		Y
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAVENOUS	215875-005	Apr 21, 2023		RX	Yes	Yes	11,207,280		Y

International Family Members for US Patent 11,207,280

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	3093725
World Intellectual Property Organization (WIPO)	2019183416